Biopharma

Pre-Movers Stocks In Analysts Rate: Pulmatrix, Inc. (NASDAQ:PULM), Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Pulmatrix, Inc. (NASDAQ:PULM) [Trend Analysis] luring active investment momentum, shares an advance 0.52% to $3.90. The total volume of 13.77 Million shares held in the session was surprisingly higher than its average volume of 5457.16 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year …

Read More »